Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: ANTI-VEGF, . Treffer: 11
2018
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
BMC CANCER. 2018; 18(1): 1074-1074.
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Smretschnig, E; Hagen, S; Glittenberg, C; Ristl, R; Krebs, I; Binder, S; Ansari-Shahrezaei, S
Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
Eye (Lond). 2016; 30(6):805-811
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Grosspotzl, M; Seidel, G; Rabensteiner, D; Haas, A
Frequency of submacular hemorrhage in age-related macular degeneration in time periods of different therapeutic modalities
SPEKTRUM AUGENHEILKD. 2015; 29(4): 149-152.
Web of Science
FullText
FullText_MUG
2013
Krebs, I; Glittenberg, C; Ansari-Shahrezaei, S; Hagen, S; Steiner, I; Binder, S
Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration.
Br J Ophthalmol. 2013; 97(11):1443-1446
Web of Science
PubMed
FullText
FullText_MUG
Michelitsch, M; Gasser-Steiner, V; Gasser-Steiner, P;
The incidence and treatment of diabetic macular edema at the University Eye-Clinic Graz for a period of 2 years.
SPEKTRUM AUGENHEILKD. 2013; 27(5): 234-238.
Web of Science
FullText
FullText_MUG
Seidel, G; Werner, C; Weger, M; Steinbrugger, I; Haas, A
Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Acta Ophthalmol. 2013; 91(6):e482-e485
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Schmid-Kubista, KE; Krebs, I; Ansari-Shahrezaei, S; Haas, P; Hagen, S; Binder, S
Comparing treatment of neovascular age-related macular degeneration with sequential intravitreal Avastin and Macugen versus intravitreal mono-therapy--a pilot study.
Curr Eye Res. 2011; 36(10):958-963
Web of Science
PubMed
FullText
FullText_MUG
2010
Prager, GW; Lackner, EM; Krauth, MT; Unseld, M; Poettler, M; Laffer, S; Cerny-Reiterer, S; Lamm, W; Kornek, GV; Binder, BR; Zielinski, CC; Valent, P
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
Mol Oncol. 2010; 4(2): 150-160.
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
D'Angelica, M; Kornprat, P; Gonen, M; Chung, KY; Jarnagin, WR; DeMatteo, RP; Fong, Y; Kemeny, N; Blumgart, LH; Saltz, LB
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
Ann Surg Oncol. 2007; 14(2):759-765
Web of Science
PubMed
FullText
FullText_MUG
Terheyden, P; Hofmann, MA; Weininger, M; Brocker, EB; Becker, JC
Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma.
J Cancer Res Clin Oncol. 2007; 133(11):897-901
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2006
Krejsgaard, T; Vetter-Kauczok, CS; Woetmann, A; Lovato, P; Labuda, T; Eriksen, KW; Zhang, Q; Becker, JC; Odum, N
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma.
Leukemia. 2006; 20(10):1759-1766
Web of Science
PubMed
FullText
FullText_MUG